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Objectives: Patients’ experience of MF/SS-CTCL remains understudied due to the 
rarity of the condition. Therefore, PatientsLikeMe (PLM) aimed to harness its internal 
platform, Open Research Exchange (ORE), to explore a novel method of data collec-
tion for the concept elicitation phase of PRO development. MethOds: Members 
of the MF/SS-CTCL community on PLM were invited to complete an online survey 
to share their experiences as patients. The 11 open-ended questions intended to 
elicit descriptions of MF/SS-CTCL quality of life impact, ability to cope and manage 
their condition, perception of symptoms and treatments, and sources of distress 
were administered to 21 patients. Of those, 10 participated in a follow-up interview. 
The data was analyzed by two trained raters and inter-rater reliability was used 
to validate and confirm their agreement. Results: The sample (N= 21) was pre-
dominantly female (67%), all white, and mostly reported MF (76%) rather than SS. 
The two raters achieved moderate to high inter-rater agreement for the qualitative 
analysis (0.68-0.80 Cohen’s kappa for the 43 validated codes). Saturation for the 
sample was reached after 15 patients. Dominant themes that were elicited from the 
data were social impact (f= 27), emotional impact (f= 30), impact on daily activities 
(f= 20), coping/management (f= 64), severity and burden of symptoms and treat-
ments (f= 377, f= 291), and overall treatment satisfaction (f= 291). cOnclusiOns: 
The online method proved to be an effective tool for understanding the experiences 
of a population living with a rare condition and complimented the interview data in 
eliciting dominant themes that were present in the literature. Utilizing ORE as the 
primary method of data collection, recruitment for this rare condition was found 
to be easier and faster than traditional methods and the sample size recruited was 
validated by concept saturation. Therefore, together, the survey and the follow-up 
interviews proved to be successful in eliciting relevant concepts from patients.
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Objectives: To develop a patient-reported outcome (PRO) instrument that assesses 
important and relevant signs, symptoms, and impacts for adult patients with pan-
creatic cancer; and to evaluate patient comprehension and usability of the draft 
Pancreatic Cancer Symptom Assessment Form (PC-SAF) administered via electronic 
diary. MethOds: Concept elicitation (CE) interviews were conducted with 18 adult 
patients with pancreatic cancer from one of six US clinic sites to identify the most 
important and relevant signs, symptoms, and impacts of pancreatic cancer. Results 
from patient interviews, clinical expert interviews, and a targeted concept litera-
ture review informed the development of the draft PC-SAF, which was evaluated 
in cognitive interviews (CI) with N= 14 adult patients with pancreatic cancer from 
one of two US clinic sites to assess patient comprehension and usability of the 
electronic instrument. Results: Gastrointestinal (GI) symptoms (loss of appetite, 
early satiety, gas/bloating, constipation, diarrhea, nausea), pain and discomfort (in 
particular, in the abdomen and back), tiredness/low energy, weight loss and physical 
weakness, jaundice, and itching emerged as predominant concepts from the patient 
CE interviews. Patients commonly reported difficulty with activities of daily living, 
and noted physical (e.g., climbing stairs, walking, standing, carrying objects), work, 
social/relationship, emotional (e.g., depression, anxiety/fear), and sleep limitations. 
Patients also reported a negative impact on overall quality of life. Results from the 
CI indicate that patients had no comprehension problems for most items; however, 
minor revisions were made to the wording of a few items (e.g., early satiety, stomach 
pain, standing) to improve clarity. No concerns were raised about the usability of the 
electronic diary; patients reported that it was easy to use. cOnclusiOns: Findings 
from this study support the content validity of the PC-SAF, a new PRO instrument 
to assess the key signs, symptoms, and impacts experienced by adult patients with 
pancreatic cancer.
PRM91
dePRession and Quality oF liFe aMong individuals With chRonic 
obstRuctive PulMonaRy disease in noRth india
Negi H.1, Raval A.2
1Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India, 2West 
Virginia University, Morgantown, WV, USA
Objectives: Although presence of depression and poor health-related quality of 
life (HRQol) lead the poor clinical outcomes in patients with COPD. However, little 
is known about the prevalence or risk factors for depressive symptoms in patients 
with chronic obstructive pulmonary disease (COPD) in India. Therefore, the current 
study was conducted to estimates rates and factors associated with depression and 
poor health-related quality of life(HRQol) in the COPD patients attending a tertiary 
care health facility in north India. MethOds: A total of 126 patients (73.81% male) 
were enrolled using convenient sampling prospectively in this cross-sectional study. 
Eligible patients were assessed for socioeconomic status, anthropometric measures, 
COPD severity, dyspnea and health status using the Hindi version of St George’s 
Respiratory Questionnaire (SGRQ). COPD was classified according to GOLD stages 
based on forced expiratory volume in one second (FEV1) in 126 stable patients. 
Depression was examined by administering the nine-item Hindi version of Patient 
Health Questionnaire-9 (PHQ-9). Linear regression model was used to identify the 
risk factors for depression and poor quality of life. Cronbach alpha was calculated 
to assess internal consistency of PHQ-9 and SGRQ. Results: Among the patients 
ferently framed opt-out alternatives in discrete choice experiments. We hypoth-
esize that within the same experiment, when opt out alternatives are framed as a 
rejection of all the available alternatives, it is likely to have a detrimental impact 
on the performance of RRM model, while the performance of RUM model suf-
fers more when the opt out is framed as a respondent being indifferent between 
the alternatives on offer. MethOds: We used two waves of data from a discrete 
choice experiment (N1 = 227; N2= 344); the first wave included an opt-out option 
implying a rejection of choice alternatives (i.e. none of these) while the second 
wave included an opt-out option implying a position of ‘indifference’ between the 
choice alternatives. We compared RUM and RRM models of different sophistica-
tions (e.g.; multinomial logit and mixed logit) in terms of parameter estimates, log 
likelihood and the Ben-Akiva and Swait test for non-nested models. Results: In 
line with hypotheses, RUM models performed significantly better (P< 0.01) than 
RRM models when opt–out alternative implied rejection of choice alternatives 
i.e. none of these. The RRM models performed significantly better (p< 0.01) than 
the RUM models when the opt-out alternative implied a position of ‘indifference’. 
RRM models had difficulty in handling the ‘none of these’ opt-out alternative 
while the RUM models had difficulty in handling the ‘indifference’ opt out alter-
native as was evident by the suspiciously large value of opt-out constant in the 
model parameter estimates for these cases. cOnclusiOns: The framing of opt 
out alternatives influences the type of behavioral framework to be considered for 
modeling.
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Objectives: The introduction of patient satisfaction metrics for pain manage-
ment as part of the Hospital Consumer Assessment of Healthcare Providers and 
Systems (HCAHPS) survey may impact decision making in postoperative pain man-
agement (POPM). The potential influence of patient satisfaction metrics, combined 
with evolving practice patterns that remain highly individualized to physicians and 
hospitals, creates a need to understand what treatment attributes influence physi-
cian selection of inpatient POPM strategies. MethOds: This adaptive approach 
conjoint analysis was a self-administered online survey of surgeons that treat POPM. 
Treatment attributes were developed based on qualitative interviews with clinicians, 
peer-reviewed literature, and input from the sponsor. The conjoint consisted of 9 
attributes (patient mobility, adverse event profile, pain control, daily cost of pain 
medication, analgesic gaps, staff utilization, medication type, route of administra-
tion, and patient satisfaction), totaling 28 levels. When considering their answers, 
respondents were asked to think of a specific type of post-surgical patient. The study 
received central IRB approval. Results: A total of 288 surgeons [male = 88%; mean 
(SD) years in practice 19(9)] were included in the study. Surgeons were screened to 
ensure they performed inpatient surgeries resulting in a need to provide inpatient 
POPM. Surgical subspecialties included general surgeons who performed abdominal/
colorectal surgeries (n= 97), gynecologic surgeons (n= 95), and orthopedic surgeons 
(n= 96). When selecting POPM strategies, surgeons valued (strength of preference) 
patient satisfaction with pain management (15.3%), a patient’s ability to mobilize 
(14.9%); adverse event profile (14.6%), and pain control effectiveness (13.6%). There 
is variability in the utility rankings by specialty. cOnclusiOns: When selecting a 
POPM strategy physicians consider a multitude of factors that go beyond the efficacy 
and safety profile of a solution. Patient satisfaction, which may be inclusive of but 
not limited to efficacy, will likely maintain or increase its influence on physician 
selection of POPM.
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Objectives: The Hyperphagia Questionnaire (HQ) is a well-established, caregiver-
reported questionnaire that focuses on food-seeking behaviors common among 
individuals with Prader-Willi syndrome (PWS). The goal of this research was to 
develop and psychometrically evaluate a modified version of the HQ for use 
within PWS clinical trials. MethOds: Following modification of the HQ based on 
industry and regulatory standards (e.g., Food and Drug Administration, 2009), the 
initial, 10-item version of the HQ for Clinical Trials (HQ-CT) was used in a phase 
2 trial with the resulting data analyzed to identify the optimal scoring approach 
and evaluate instrument psychometric properties. Next, further evaluation by 
clinical experts in PWS and regulatory authorities resulted in removal of an item 
that focused more on patient-caregiver interactions than direct observation of 
patient behavior. Qualitative interviews were then conducted with PWS caregivers 
to inform final refinements, provide additional support for content validity, and 
assess usability of the electronic (ePRO) version of the 9-item measure. Results: 
Initial modifications to the HQ reduced the recall period, optimized response 
scales, and limited item content to observable behaviors that have the potential 
to change during the course of a clinical trial. Psychometric evaluation supported 
the use of a single HQ-CT composite score as well as the questionnaire’s reliability 
and validity. The HQ-CT total score was also able to demonstrate improvements 
in hyperphagia-related behavior between treatment groups. Finally, qualita-
tive interviews with 6 caregivers supported the relevance and comprehensive-
ness of the content, item clarity, and the ePRO version of the HQ-CT’s ease of 
use. cOnclusiOns: Qualitative and quantitative evidence provide support for 
use of the 9-item HQ-CT total score for the assessment of food-seeking behav-
iors in PWS clinical trials. The HQ-CT is currently being used in a phase 3 PWS 
study.
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Objectives: Fatigue is an important symptom for multiple sclerosis (MS) patients. 
Qualitative research supported initial content validity of the FSIQ-RMS™,1 the 
first patient-reported outcome (PRO) measure of fatigue in relapsing (R)MS 
developed according to the 2009 FDA PRO guidance. To confirm appropriate-
ness, validity, and reliability of the FSIQ-RMS, further psychometric analyses 
were required. MethOds: The FSIQ-RMS™ with 9 Symptom items (daily recall 
period, 1 subdomain) and 14 Impact items (weekly recall period, 3 subdomains) 
was administered over 3 months (three 7-day intervals) in a multicenter, non-
interventional, US-based, IRB-approved study to adult patients with different RMS 
subtypes (relapsing remitting, secondary progressive, progressive relapsing) and 
a subset of matched healthy controls (week 1 only). Data analyses included: item 
response and dimensionality; content and construct validity; internal consistency 
and test-retest reliability; as well as attribution of fatigue to RMS. Evaluations 
were supported by those from a cross-sectional, multicenter study, in which RMS 
patients completed the FSIQ-RMS™ Symptoms domain. Results: The psycho-
metric validation study included 164 RMS patients (mean age 45 [range 19–65] 
years; 76% female) and 74 controls (40 [18–65] years; 73% female). Two redundant 
Symptom items were deleted, leaving 7; Impact items were unchanged. A 0–100 
scoring algorithm was developed for the FSIQ-RMS™ (sub)domains. Internal con-
sistency (Cronbach’s alpha 0.87–0.97) and test-retest reliability (intraclass cor-
relation coefficient [ICC] 0.92–0.95) of all (sub)domains exceeded pre-specified 
thresholds (alpha> 0.70; ICC≥ 0.70). The Symptoms domain discriminated along the 
symptom-severity continuum of RMS patients and between patients and healthy 
controls. Patients were able to attribute fatigue-related symptoms to RMS (14-point 
difference vs. controls; P< 0.0001). Findings were supported by those from the 
cross-sectional study (N= 154). cOnclusiOns: Content and measurement validity 
of the revised final FSIQ-RMS™ were confirmed. Responsiveness of the PRO will 
be evaluated in a Phase III trial. 1Value Health 2014;17(3):A195-6.
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Feasibility oF using the sF-36 health suRvey to scReen FoR Risk oF 
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Objectives: To assess the feasibility of the SF-36v2 Mental Health (MH) domain 
and Mental Component Summary (MCS) scores in the classification of risk for 
major depressive disorder (MDD), and determine the cutoff scores in a US sam-
ple and chronic pain subpopulations. MethOds: Data were analyzed from the 
2013 US National Health and Wellness Survey (adults ≥ 18 years old; N= 75,000). 
Respondents were also classified into subpopulations based on self-report: chronic 
pain (n= 6,679) and chronic pain receiving medication for depression (i.e. with 
depression) (n= 5,814). The primary definition for classifying respondents at risk 
of MDD was a score > 10 on the Patient Health Questionnaire (PHQ-9). Logistic 
regression modeling was used to predict at risk for MDD, or not, and receiver 
operating characteristic curves were produced. Results: The total sample had 
MH scores of 48.8 and MCS scores of 48.9, similar to the normative mean for the 
US adult population. The percent of respondents with a PHQ-9 > 10 were 15.0%, 
29.1% and 25.9% for the total sample, chronic pain alone, and chronic pain with 
depression, respectively. Cutoff scores (PHQ-9> 10) in the total sample for the MH 
domain and MCS were 43.0 and 46.0, respectively. Specificities of recommended 
cutoff scores for the MH domain and MCS were 77.8% and 76.1%; sensitivities 
were 84.9% and 88.1%. Among the subpopulation with chronic pain alone, cutoff 
scores for the MH domain and MCS were 40.4 and 43.1, respectively. Corresponding 
specificities for the MH domain and MCS were 77.9% and 73.9%; sensitivities were 
78.3% and 83.4%. Trends were similar among the chronic pain with depression 
subpopulation. cOnclusiOns: The SF36v2 was found to have sufficient specific-
ity and sensitivity to categorize participants at risk for MDD. It is feasible to use 
the SF-36v2, a widely used measure to assess health status, to better characterize 
the mental health of populations.
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Objectives: Little is known about estimating utilities for comorbid (or ‘joint’) 
health states. Several joint health state prediction models have been suggested (for 
example, additive, multiplicative, best-of-pair, worst-of-pair, etc.) but no general 
consensus has been reached. Without preconceptions about the preferred func-
tional form, this study explores the relationship between health-related quality of 
life (HRQoL) and increasing numbers of diagnoses. MethOds: We analyzed a large 
dataset containing respondents’ ICD-9 diagnoses and preference-based HRQoL 
(EQ-5D and SF-6D). Data were stratified by the number of diagnoses and mean 
HRQoL values were estimated. Several adjustments, accounting for the respond-
ents’ age, sex and the severity of the diagnoses were carried out. Our analysis fitted 
additive and multiplicative models to the data, and assessed model fit using mul-
tiple standard model selection methods. Results: A total of 39817 respondents 
were included in the analyses. Average HRQoL values were represented well by 
both linear and multiplicative models. Although results across all analyses were 
similar, adjusting for severity of diagnoses, age and sex strengthened the linear 
model’s performance measures relative to the multiplicative model. Adjusted 
values were above 0.99 for all analyses (i.e. all adjusted analyses, for both HRQoL 
instruments), indicating a robust result. cOnclusiOns: Additive and multiplica-
tive models perform equally well within our analyses. Presupposing that a lin-
ear model is simpler than an additive one, we conclude that the additive model 
should be preferred unless compelling evidence is produced to show that the 
models diverge.
with COPD, a total of 33.3% patients showed moderate to severe depressive symp-
toms and nearly 50% of cases had a marked impairment in HRQol. Educational and 
occupational status, body mass index, FEV1, respiratory symptoms, physical impair-
ment and dyspnoea were associated with the diagnosis of depression in patients 
with COPD, whereas, body- mass-index, forced expiratory volume in 1 second (FEV1 
), dyspnea grade, and depression were associated with poor HRQL in patients with 
COPD. cOnclusiOns: More than one third of patients with COPD had either depres-
sion or poor HQol in India. The study suggest need for regular screening for depres-
sion and HRQol in patients with COPD especially among obsese and patients with 
comprosised or severe respiratory functions.
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Objectives: As a disease characterized by pain, Patient-Reported Outcomes (PROs) 
are important for determining disease severity and evaluating the efficacy of endo-
metriosis treatments. In the absence of existing PROs that comply with the FDA PRO 
Guidance, two new PROs have been developed: The Endometriosis Symptom Diary 
(ESD) and Endometriosis Impact Scale (EIS). The content validity of these instruments 
has been demonstrated by extensive qualitative and quantitative research with 
women with endometriosis. The first investigations of the reliability and validity of 
scores derived from the ESD and EIS are presented herein. MethOds: Women with 
surgically-confirmed endometriosis (n= 268) in the US and Germany participated in 
a 12-week non-interventional study. A range of PRO measures were completed by 
participants throughout the study using an electronic handheld device, including: 
ESD, EIS, Biberoglu & Behrman Scale, Endometriosis Health Profile-30, Patient Global 
Impression of Severity and Change measures and single-item pain numerical-rating 
and visual analogue scales. Pre-specified analyses were conducted to evaluate the 
test-retest reliability, convergent validity, known-groups validity and responsiveness 
of scores derived from the ESD and EIS. Results: Intraclass correlation coefficients 
among participants classified as ‘stable’ support the test-retest reliability of ESD/EIS 
scores. Correlations between scores for the ESD/EIS and concurrent measures were 
consistent with a priori hypotheses, demonstrating convergent validity. Furthermore, 
Analysis of Covariance models revealed statistically significant (p< 0.05) differences 
in ESD/EIS scores among participants of varying levels of symptom severity (as deter-
mined by scores on concurrent measures). Finally, observed ESD/EIS score changes 
in participants whose clinical status had improved (according to scores on concur-
rent measures) were significantly greater than those who had not improved/changed, 
providing evidence of responsiveness. cOnclusiOns: Findings support the reliability 
and validity of scores derived from the ESD and EIS. Future research will seek to explore 
definitions of meaningful change in ESD/EIS scores using data from clinical studies.
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Objectives: Selection of response scales for patient-reported outcome (PRO) 
measures is often driven by therapeutic area convention or preferences of measure 
developers. To help guide response scale selection, an objective of this project was 
to identify empirical evidence supporting the responsiveness of common response 
scale types. MethOds: A comprehensive literature review was conducted for stud-
ies published from January 2004 through October 2014 that provided direct compari-
sons of responsiveness of different response scale types. Additional searches were 
conducted for abstracts and presentations on this topic from relevant scientific con-
ferences. Results: The most common types of response scales evaluated were the 
100mm visual analog scale (VAS), the 11-point numeric rating scale (NRS), and the 
verbal rating scale (VRS) (with varying number of levels). Three studies directly com-
pared responsiveness of all three types. Of these, one found no difference in respon-
siveness of the three types, one found superior responsiveness for the NRS compared 
to the VAS, and one found the VAS to be most responsive for one domain while the 
NRS was most responsive for another. Three studies compared VAS to VRS, with one 
finding no difference and one study each finding greater responsiveness for the VAS 
and a 7-point VRS, respectively. Four studies compared NRS vs. VRS, with three dem-
onstrating no difference and one demonstrating superior responsiveness for the NRS 
compared to a 6-point VRS. cOnclusiOns: There are a number of considerations in 
response scale selection, including target population, study design, concept of interest, 
recall period, data collection mode, and scale responsiveness. Several reviewed studies 
demonstrated equivalent responsiveness for the most common response scale types; 
however, evidence suggests the 11-point NRS may be slightly more responsive than the 
other response scales in some settings. Limitations of this review include its 10-year 
timeframe and the paucity of empirical studies comparing common response scales.
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